Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 43063-407

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 43063-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063407)

This medication contains 100 mg of Orphenadrine Citrate ER and comes in a pack of 20 tablets. It is important not to crush or chew the tablets and to use caution when driving or performing tasks that require mental alertness. It may cause dizziness and should be kept out of the reach of children. Dosage and storage instructions can be found in the package insert. Side effects should be reported to a doctor or the FDA. The tablets are round and have "N4" marked on them. The manufacturer is based in Oklahoma City. Overall, this is a product warning and description data.*

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.